In Arizona, joining the ranks of Akron Biotechnology and others we’ve covered in the past, Lattice Biologics Ltd. is joining nearly 100 organizations in the Advanced Regenerative Manufacturing Institute (ARMI) an initiative comprised of public sector, government, nonprofits, and private sector aimed to advance next-generation technologies and biofabrication for cells, tissue and organs. Lattice Biologics is using human tissue based scaffolds that can support ingrowth of stem cells, preserve phenotypes of engrafted cells, and improve the time it takes for patients to heal. They use extracellular matrix from stem cells or from muscle or placenta tissue to create their biomaterial for cellular therapies and tissue engineering. Lattice Biologics is working with Arizona-based ASU Biodesign on their products.
Latest article
University of Edinburgh researchers bring us a step closer to space bacon
In Scotland, researchers from the University of Edinburgh’s Roslin Institute have created a pig cell line capable of producing fat cells with “remarkable consistency”...
Lab-grown leather pioneer Faircraft acquires assets from DiCaprio-backed VitroLabs
In Paris, biotech start-up Faircraft has announced the acquisition of key assets from U.S.-based VitroLabs, a pioneering player in the lab-grown leather industry that...
Teysha outfits Everest team with biodegradable eyewear
In the United Kingdom, Teysha Technologies is supplying four former special forces soldiers with biodegradable sunglasses as they attempt a world record on the...